SynthesisJAMA network open2023

Comparison of Anti-Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis.

Brigida Anna Maiorano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.